PORT WASHINGTON, N.Y.–Pall Corporation today announced that its board of directors declared a 20 percent increase in its quarterly dividend to 21 cents per share. “The board has increased the dividend again this year in support of our long-term commitment to create more value for our shareholders,” said Larry Kingsley, president & CEO. “We continue […]
SANTA CLARA, Calif.–Agilent Technologies Inc. (NYSE:A) today announced that on Jan. 17, 2012, its board of directors approved the initiation of quarterly cash dividends to its shareholders and declared the first cash dividend in the company’s history. A quarterly dividend of 10 cents per share of common stock will be paid on April 25 to […]
Uniqsis of Cambridge, UK, and WaveCraft of Uppsala, Sweden, have entered into a collaborative agreement to develop and market a new range of microwave-based flow chemistry systems that will radically improve efficiency when scaling up compound synthesis during drug development. By integrating proven liquid handling technology from Uniqsis with unique microwave applicator technology and reactors […]
CARLSBAD, Calif. — Life Technologies Corporation (NASDAQ: LIFE) announced today that it has given notice of its intention to redeem all of the outstanding 1.5% Convertible Senior Notes due 2024 (the “2024 Convertible Notes”) on February 15, 2012. As of December 31, 2011 there was $450,000,000 in aggregate principal amount of the 2024 Convertible Notes […]
Jena (Germany) — Management Board and Supervisory Board of CyBio AG (Deutsche Börse, General Standard, ISIN DE005412308) today decided to submit the proposal to the Shareholder’s Meeting on April 27, 2012, to authorize the Management Board to apply for withdrawing from the listing of CyBio AG shares on the Regulated Market at Frankfurt Stock Exchange […]
AN DIEGO — Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced highlights of the Company’s 2011 performance and accomplishments, as well as preliminary activities and goals for the first part of 2012. Initial 2011 Performance Results Total revenue growth of approximately 23 percent year-over-year for 2011 (unaudited). Over […]
OMAHA, Neb. – Transgenomic, Inc. (OTC/BB: TBIO) today announced that it has entered into a Convertible Promissory Note Purchase Agreement (the “Purchase Agreement”) in the aggregate amount of $3.0 million with entities (the “Investors”) associated with Third Security, LLC, a leading life sciences investment firm. “We are very pleased with the additional investment by Third […]
WARREN, N.J. — Roka Bioscience announced today that it has secured $47.5 million in Series D financing. New investor Aisling Capital participated in the financing along with existing investors OrbiMed Advisors, New Enterprise Associates, Inc., and TPG Biotech. In conjunction with the financing, Josh Bilenker, M.D., Partner at Aisling Capital, will join Roka’s Board of […]
CAMBRIDGE, Mass. — Quanterix Corporation, a company enabling a new generation of molecular diagnostic tests based on its revolutionary Single Molecule Array (SiMoA™) technology, announced today a strategic investment and technology development agreement with In-Q-Tel (IQT), the independent strategic investment firm that identifies innovative technology solutions to support the missions of the U.S. Intelligence Community. […]
MINNEAPOLIS — MOCON, Inc., announced today that on December 15, 2011, its Board of Directors declared a quarterly cash dividend of ten cents ($0.10) per share, payable on February 17, 2012, to shareholders of record on February 3, 2012. The Company has provided stockholders with quarterly dividends for the 94th consecutive quarter. Prior to the […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
